Abstract: Random numbers, as a cornerstone in the interconnected digital world, are used in secure cryptographic protocols for commercial transactions, computing, and communications. Instead of the ...

Most people treat Excel as a rigid calculator, completely missing its capacity for chaos. Excel's built-in randomization tools can generate numbers, shuffle existing lists, and build mock timelines in ...

Encryption systems rely on “random” numbers, but conventional computers can’t generate them perfectly. New research shows that quantum physics can. By Alexander Nazaryan Researchers in Switzerland ...

Researchers in Switzerland claim to have built a perfect random number generator from two quantum superconducting chips, a 30-meter-long pipe, and some software. The resulting device could be used to ...

Creating perfect randomness is surprisingly difficult. Even modern random number generators never generate completely ideal random numbers: small systematic errors can result in some numbers appearing ...

Australia's water supplies are evaporating. According to researchers at Deakin University, the country's water infrastructure loses nearly 370 billion gallons every year due to evaporation, about ...

I rarely write articles about 3D graphics, because it feels like everything has already been said and written a hundred times. But during interviews, especially when hiring junior developers, I ...

Explore how next-gen game engines like Unity and Unreal Engine technology are evolving, powering advanced graphics, cross-platform development, and real-time 3D experiences across games and beyond.

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Generate:Biomedicines has already earmarked $300 million of the IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (jxfzsy/iStock/Getty Images Plus) ...